Glenmark Pharmaceuticals Ltd: Income statement and analysis

Overview Forecasts Financials Peers Holdings News Events

Consolidated
Financial Statements

Income

Balance Sheet

Cash Flow

What is an income statement?

The income statement indicates a company's financial performance measured over a reporting period. Performance is assessed by summarising how the business incurs its revenues, expenses and net profit or loss incurred over the period. It's also called the P&L statement

Income Statement
Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 6.47%, vs industry avg of 7.66%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 4.72% to 4.29%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -3.21%, vs industry avg of 4.09%

Financial Year	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	TTM
Total Revenue	6,016.68	6,687.81	7,581.67	9,116.78	9,165.82	10,240.79	10,833.45	11,038.69	12,471.57	13,133.62
Raw Materials	1,813.35	2,132.36	2,442.74	3,073.93	2,904.86	3,421.01	3,570.56	3,809.43	4,323.22	10,581.27
Power & Fuel Cost	93.50	109.11	120.47	127.02	137.48	165.26	173.69	164.67	200.64
Employee Cost	1,026.15	1,212.61	1,378.20	1,640.81	1,871.84	2,056.07	2,254.78	2,343.71	2,447.42
Selling & Administrative Expenses	1,037.68	1,317.12	1,395.79	1,589.86	1,523.27	1,750.21	1,667.02	1,453.55	1,543.27
Operating & Other expenses	943.74	882.51	787.32	692.04	1,021.60	887.12	1,276.84	1,088.19	1,730.97
EBITDA	1,102.26	1,034.10	1,457.15	1,993.12	1,706.77	1,961.12	1,890.56	2,179.14	2,226.05	2,552.35
Depreciation/Amortization	216.80	300.41	234.28	264.37	301.88	325.91	417.17	443.55	486.72	596.27
PBIT	885.46	733.69	1,222.87	1,728.75	1,404.89	1,635.21	1,473.39	1,735.59	1,739.33	1,956.08
Interest & Other Items	188.59	190.15	178.89	237.32	285.57	334.59	377.32	353.11	298.10	327.18
PBT	696.87	543.54	1,043.98	1,491.43	1,119.32	1,300.62	1,096.07	1,382.48	1,441.23	1,628.90
Taxes & Other Items	154.60	334.00	300.94	382.67	315.46	375.63	320.11	412.44	499.54	747.78
Net Income	542.27	209.54	743.04	1,108.76	803.86	924.99	775.96	970.04	941.69	881.12
EPS	20.01	7.72	26.85	39.29	28.49	32.78	27.50	34.38	33.37	31.23
DPS	0.00	2.00	2.00	2.00	2.00	2.00	2.50	2.50	2.50	2.50
Payout ratio	0.00	0.26	0.07	0.05	0.07	0.06	0.09	0.07	0.07	0.08